A new scientist joining UF Scripps Biomedical Research, James M. Burke, Ph.D., is exploring how our innate immune system protects us from viruses — including the pandemic coronavirus — and how viruses evade these defenses.
Promising new drugs sometimes fail when they reach clinical trials despite strong early data. A new scientist joining UF Scripps Biomedical Research aims to address this problem with new chemistry tools that map interactions within cells.
Multiple scientists from UF Scripps Biomedical Research will join a massive federal effort to develop antiviral drugs to treat the pandemic coronavirus and other viral threats.
UF Scripps Biomedical Research scientist Matthew Disney, Ph.D. has found yet another groundbreaking approach to a problem that has long vexed scientists: How to cure diseases by targeting key RNA. Until now, RNA has been an elusive target for drug discovery. Discoveries made by Disney and his collaborators have rewritten that dogma.
Management of financial and administrative operations at UF Scripps Biomedical Research, the Jupiter-based scientific research institute, will be overseen by James Lapple, MBA, CPA, the current vice president for finance at the Rockefeller University in New York.
For people with autism, overstimulating sensory experiences such as noise can have a profound effect on their lives. Now, a group of scientists at UF Scripps Biomedical Research has shed new light on brain development that can lead to autism-related sensory processing disorders.
Two of the nation’s most respected research institutions have closed their transaction that adds a Florida powerhouse meant to accelerate the pace of biomedical discoveries that benefit patients. Effective April 2, the Florida campus of Scripps Research is integrated with and will now be part of the University of Florida’s academic health center as UF Scripps Biomedical Research.